Want to see FOFA full AI Analyst Report?
Family Office of America (FOFA) AI Stock Analysis
Family Office of America
(Other OTC:FOFA)
FOFA scores in the lower band primarily because its financial profile, while improving, remains speculative: the company is still unprofitable, its revenue base is very small and volatile, and liabilities account for most of a modest asset base. The improving trajectory — revenue growth, ~96% gross margins, positive book equity, low leverage and a recent swing to positive free cash flow — is the main offset but needs several quarters of consistency to be considered durable. Technicals reinforce the caution, with the price trading below its 50-, 100- and 200-day averages and negative MACD momentum, though a deeply oversold stochastic reading hints at short-term stabilisation. Valuation adds no support given negative earnings and the absence of a dividend. Earnings call and corporate event components were excluded due to a lack of data, with their weight redistributed across the remaining factors.
Family Office of America (FOFA) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $24.04M
- Dividend Yield
- ―
- Average Volume (3M)
- 509
- Price to Earnings (P/E)
- -121.9
- Beta (1Y)
- -0.22
- Revenue Growth
- ―
- EPS Growth
- 50.47%
- Country
- US
- Employees
- 5
- Sector
- Industrials
- Sector Strength
- 63
- Industry
- Specialty Business Services
Family Office of America Business Overview & Revenue Model
Company Description
Family Office of America, Inc. is building an integrated family office platform through the acquisition and operation of accounting, tax, bookkeeping and related professional service businesses. The Company's strategy is to acquire established busine...
Family Office of America Financial Statement Overview
Summary
A micro-cap turnaround in its earliest stage. Positives include a revenue inflection to roughly $1.54 million TTM from near zero, exceptional ~96% gross margins, a ~90% reduction in losses since 2021, a swing to positive shareholders' equity of about $997 thousand, low leverage (0.31 debt-to-equity), and a flip to roughly $195 thousand of positive operating and free cash flow after years of burn. Offsetting these, the company remains unprofitable at every level (net margin near -10%, return on equity around -18%), liabilities make up the majority of a very small $2.65 million asset base, and results have been highly volatile year to year, leaving the profile speculative and dependent on execution.
Income Statement
38NegativeBalance Sheet
45NeutralCash Flow
48Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.54M | 221.76K | 0 | 0 | 0 | 0 |
| Gross Profit | 1.43M | 221.76K | 0 | -17.25K | 0 | 0 |
| EBITDA | -64.60K | -449.15K | -95.01K | -223.00K | -560.90K | -1.14M |
| Net Income | -155.56K | -492.75K | -100.48K | -805.00K | -921.00K | -1.73M |
Balance Sheet | ||||||
| Total Assets | 2.65M | 1.54M | 20.58K | 2,431 | 295.46K | 800.06K |
| Cash, Cash Equivalents and Short-Term Investments | 636.89K | 155.80K | 13.59K | 2,431 | 69.86K | 528.28K |
| Total Debt | 520.32K | 300.00K | 0 | 9,102 | 31.19K | 0 |
| Total Liabilities | 1.65M | 878.53K | 44.02K | 525.39K | 71.51K | 29.65K |
| Stockholders Equity | 997.20K | 664.51K | -23.44K | -522.96K | 223.95K | 770.41K |
Cash Flow | ||||||
| Free Cash Flow | 195.50K | -822.79K | -89.37K | -76.53K | -558.43K | -794.63K |
| Operating Cash Flow | 195.50K | -262.19K | -89.37K | -76.53K | -558.43K | -792.84K |
| Investing Cash Flow | -598.71K | -560.60K | 0 | 0 | 0 | -1,787 |
| Financing Cash Flow | 455.00K | 965.00K | 100.53K | 9,102 | 100.00K | 1.25M |
Family Office of America Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FOFA, the sentiment is Negative. The current price of 0.78 is below the 20-day moving average (MA) of 0.88, below the 50-day MA of 0.89, and below the 200-day MA of 1.10, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 24.04 is Positive, neither overbought nor oversold. The STOCH value of -1.13 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FOFA.
Family Office of America Peers Comparison
Overall Rating
CLRB48Neutral
SNGX47Neutral
AKTX46Neutral- FOFA43Neutral
ALUR39Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 63Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |
| CLRB | 48Neutral | $11.39M | -0.26 | -165.71% | ― | ― | 77.68% |
| SNGX | 47Neutral | $7.75M | -0.28 | -181.02% | ― | ― | 66.94% |
| AKTX | 46Neutral | $14.42M | -0.01 | -147.45% | ― | ― | ― |
| FOFA | 43Neutral | $24.12M | -121.88 | -18.13% | ― | ― | 50.47% |
| ALUR | 39Underperform | $20.51K | 0.00 | 44.17% | ― | -55.49% | 21.55% |
* Industrials Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FOFA | Family Office Of America Inc | 0.78 | 0.24 | 44.01% | |
| SNGX | Soligenix Inc | 0.35 | -1.11 | -75.85% | |
| CLRB | Cellectar Biosciences Inc | 1.21 | -2.09 | -63.48% | |
| AKTX | Akari Therapeutics PLC (ADR) | 8.24 | -20.76 | -71.59% | |
| ALUR | Allurion Technologies, Inc. | 0.02 | -27.13 | -99.93% | |
| MGRX | Mangoceuticals, Inc. | 0.23 | -1.63 | -87.47% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Aug 19, 2026